Article
Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate.
Oncotarget - 13 Dec 2016
Schweizer Michael T, Cheng Heather H, Tretiakova Maria S, Vakar-Lopez Funda, Klemfuss Nola, Konnick Eric Q, Mostaghel Elahe A, Nelson Peter S, Yu Evan Y, Montgomery Bruce, True Lawrence D, Pritchard Colin C
Abstract excerpt
Precision oncology entails making treatment decisions based on a tumor's molecular characteristics. For prostate cancer, identifying clinically relevant molecular subgroups is challenging, as molecular profiling is not routine outside of academic centers. Since histologic variants of other cancers correlates with specific genomic alterations, we sought to determine if ductal adenocarcinoma of the prostate (dPC) -...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.